--2023/Q2120.700M / ----
--2022/Q480.749M / 68.850M--
--2022/Q355.300M / ----
--------
--------
NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Alibaba
BABA
US Stock MarketDetailed Quotes
TLX Telix Pharmaceuticals
- 19.205
- -0.295-1.51%
Close Feb 26 16:00 ET
- 20.000
- +0.795+4.14%
Post 18:02 ET
6.43BMarket Cap202.16P/E (TTM)
20.400High19.130Low86.32KVolume19.400Open19.500Pre Close1.69MTurnover0.51%Turnover Ratio202.16P/E (Static)334.72MShares30.36052wk High17.83P/B326.49MFloat Cap14.01052wk Low--Dividend TTM17.00MShs Float30.360Historical High--Div YieldTTM6.51%Amplitude14.010Historical Low19.549Avg Price1Lot Size
Telix Pharmaceuticals Key Stats
Telix Pharmaceuticals FY2024 Annual Report Date
Currency：USDFeb 19, 2025
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 484.08M | 487.29M | +3.21M |
| Beat Est. | +41.46% | +42.40% | +0.66% |
| EPS | 0.12 | 0.09 | -0.03 |
| Miss Est. | -- | +720.64% | -25.00% |
Analyst Rating
No Data
Telix Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: AUD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account